Búsqueda avanzada

En la actualidad, Helen W. Crossen ocupa el cargo de directora administrativa de Annaly Capital Management, Inc. Anteriormente, la Sra. Crossen ocupó el cargo de Vicepresidenta de Recursos Humanos de NBC Universal, Inc. La Sra. Crossen se licenció y se graduó en la Universidad Estatal Rutgers de Nueva Jersey.

Helen I. Torley ocupa el cargo de Presidenta, Directora General y Directora de Halozyme Therapeutics, Inc. También forma parte del consejo de Quest Diagnostics, Inc. y es directora y miembro del consejo de administración de la sección de salud de la Organización de Innovación Biotecnológica y miembro del Real Colegio de Médicos. En el pasado fue Vicepresidenta y Directora General de Salud Ósea de Estados Unidos en Amgen, Inc. y Directora Comercial y Vicepresidenta Ejecutiva de Onyx Pharmaceuticals, Inc. (una filial de Amgen, Inc.), Vicepresidenta de Asuntos Médicos de Novartis, Inc., Vicepresidenta de Asuntos Médicos de Sandoz SA y Vicepresidenta de Ventas Cardiovasculares y Metabólicas del Grupo Mundial de Medicamentos de Bristol-Myers Squibb. Se licenció en la Universidad de Glasgow.

Helen Jane Ashton is the founder of Fire Bright Solutions Ltd., which was founded in 2003.
She is currently an Independent Non-Executive Director at JD Sports Fashion Plc, Director at JLA Total Care Ltd., Director at Direct Catering Products Ltd., Director at Astral Fire & Security Ltd., Director at Atlas Sterile Services Ltd., Director at Atlas Services Holdings Ltd., and Director at T Jolly Facility Services Ltd.
Ms. Ashton's former positions include Chief Executive Officer & Director at Vanilla Group Ltd., Chief Executive Officer at Capquest Group Ltd., Chief Executive Officer at JLA Ltd., Director at JLA EquityCO Ltd.
from 2019 to 2020, Chief Financial Officer at ASOS Plc in 2018, and Chief Operating Officer at Arrow Global Group Ltd.
She obtained an undergraduate degree from The University of Manchester.

Helen Miles is currently the Chief Financial Officer & Executive Director at Severn Trent Plc since 2014.
She is also an Independent Non-Executive Director at Breedon Group Plc since 2021.
Additionally, she holds a position as a Non-Executive Director at the Royal Navy.
Previously, she worked as a Director at Hafren Dyfrdwy Cyfyngedig, Chief Financial Officer at Corente, Inc., and Chief Financial Officer at Openreach Ltd.

Helen McCabe currently works at Rolls-Royce Holdings Plc, as Chief Financial Officer & Director from 2023, Rolls-Royce Group Ltd., as Director from 2023, and Rolls-Royce Plc, as Chief Financial Officer from 2023.

Fundadora de Next Generation Now, Inc., Helen P. Johnson-Leipold es una empresaria que ha estado al frente de 8 empresas diferentes y que actualmente ocupa el cargo de presidenta y directora general de Johnson Outdoors, Inc., presidenta de Johnson Keland Management, Inc. y presidenta de Johnson Financial Group, Inc. y de Johnson Bank (Wisconsin). También forma parte del consejo de administración de S.C. Johnson & Son, Inc., Commercial Markets Holdco, Inc. y The Prairie School, Inc. y del consejo de administración de The Johnson Foundation at Wingspread. Anteriormente fue presidenta de Diversey, Inc., presidenta de Next Generation Now, Inc. y presidenta de Diversey Holdings LLC y directora de Foote, Cone & Belding Worldwide. Se licenció en la Universidad de Cornell.

Helen A. Coonan es presidenta del Minerals Council of Australia, presidenta ejecutiva de Crown Resorts Ltd., presidenta de Australian Financial Complaints Authority Ltd., presidenta de Crown Resorts Foundation Ltd., presidenta de Supervised Investments Australia Ltd., presidenta de Sydney Harbour Foreshore Authority, copresidenta de GRACosway, miembro de Chief Executive Women, Inc. y miembro del Consejo Corporativo del European Australian Business Council. Forma parte del Consejo de Administración de Burswood Ltd., Crown Melbourne Ltd., Crown Perth, Crown Sydney Gaming Pty Ltd., Australian Children's Television Foundation, Obesity Australia Ltd. y Sydney Opera House. Anteriormente, la Sra. Coonan fue presidenta no ejecutiva de HGL Ltd., directora no ejecutiva de Snowy Hydro Ltd., ministra de Hacienda del Parlamento australiano, socia de Gadens Lawyers (Australia) y copresidenta de Government Relations Australia Advisory Ltd. Se licenció en la Universidad de Sydney y se graduó en la Universidad de Sydney.

Helen Marie Boudreau is currently an Independent Director at CARA Therapeutics, Inc., Premier, Inc., Shattuck Labs, Inc., Rallybio LLC, Field Trip Health, Inc., Field Trip Psychedelics, Inc., Rallybio Corp., and Managing Director at Estuary Ventures LLC.
Previously, she held positions as Director-Strategic Planning at Yum!.
Brands, Inc., Independent Director at Evaxion Biotech A, Independent Director at Field Trip Health Ltd., Independent Director at Reunion Neuroscience, Inc., Principal at Bank of America Corp., Vice President-Finance, Research & Development at Pfizer Inc., Chief Financial Officer & VP-Investor Relations at Novartis Oncology, Inc., Chief Financial Officer at Novartis Corp., Chief Financial Officer at Forma Therapeutics, Inc., Engagement Manager at McKinsey & Co., Inc., Treasurer, Chief Financial & Accounting Officer at Proteostasis Therapeutics, Inc., and Chief Operating Officer at Bill & Melinda Gates Medical Research Institute.
She obtained an MBA from the University of Virginia Darden School of Business in 1993.

Helen M. Nugent es una empresaria que ha estado al frente de 15 empresas diferentes. En la actualidad, ocupa el cargo de presidenta de la National Portrait Gallery (Australia), presidenta de la National Disability Insurance Agency y presidenta de Veda Group Pty Ltd. También es presidenta de la Cranbrook School, presidenta de la National Opera Review del Gobierno de Australia y rectora de la Bond University, además de formar parte del consejo de administración de otras cinco empresas. En el pasado, la Dra. Nugent ocupó los cargos de Presidenta del Aeropuerto de Sydney, Presidenta del Consejo Australiano de las Artes, Directora de Estrategia de Westpac Banking Corp., Presidenta del Grupo Australiano de Grandes Artes Escénicas, Presidenta de Superannuation Funds Management Corp. of South Australia, Presidenta no ejecutiva de Ausgrid Pty Ltd, Presidente no ejecutivo independiente de Equifax Pty Ltd., Presidente de The Mercantile & General Reinsurance Co. of Australia Ltd., Presidente no ejecutivo independiente de Equifax Australia Group Pty Ltd., Presidente de Hudson Global Resources (Aust) Pty Ltd., Presidente de Australian Rail Track Corp. Ltd., Presidente de Hudson Global Resources (NZ) Ltd., Presidente de Swiss Re Australia Ltd., Miembro de la Revisión de la Educación Superior Australiana del Departamento de Educación y Formación de Australia, Socio de Mckinsey & Co., Profesor de la Universidad de Nueva Gales del Sur y Profesor de la Australian Graduate School of Management. Helen M. Nugent se doctoró y se licenció en la Universidad de Queensland y obtuvo un MBA en la Universidad de Harvard.

Helen L. Shan es directora independiente de EPAM Systems, Inc. y directora financiera y de ingresos de FactSet Research Systems, Inc. Es miembro del Consejo de Administración de EPAM Systems, Inc., FactSet Europe Ltd. y Vermilion Holdings Ltd. Anteriormente, la Sra. Shan fue directora financiera de Mercer Consulting Group, Inc., tesorera y vicepresidenta de Marsh & McLennan Cos, Inc., tesorera y vicepresidenta de Pitney Bowes, Inc., directora general de industrias diversificadas de JPMorgan Securities LLC, y controladora de Salomon Brothers. Se licenció en la Wharton School de la Universidad de Pensilvania, en la School of Engineering & Applied Science y obtuvo un MBA en la Johnson Graduate School of Management.

Actualmente, Helen Giza ocupa el cargo de Directora Financiera de Fresenius Medical Care AG & Co. KGaA y Directora Financiera y Miembro del Consejo de Administración de Fresenius Medical Care Management AG. También forma parte del consejo de administración de Fresenius Medical Care Holdings, Inc. Anteriormente, ocupó el cargo de Controladora de Área Comercial-Región Asia-Pacífico en Abbott Laboratories, Vicepresidenta y Controladora de División en TAP Pharmaceutical Products, Inc, Contable de Costes en ITT, Inc y Directora de Integración y Gestión de Desinversiones en Takeda Pharmaceuticals International, Inc. Obtuvo un MBA en la Kellogg School of Management.

Helen Lofthouse is currently the CEO, Managing Director & Executive Director at ASX Ltd.
She also holds director positions at ASX Clearing Corp.
Ltd., ASX Clear (Futures) Pty Ltd., ASX Clear Pty Ltd., ASX Settlement Corp.
Ltd., ASX Settlement Pty Ltd., and Austraclear Ltd.
Previously, she worked as a Managing Director at UBS Group AG from 2011 to 2015.

Siv Helen Rygh Torstensen es Vicepresidenta Senior de Asuntos Legales y Asesora General del Grupo en Equinor ASA. La Sra. Torstensen se licenció en la Universidad de Bergen.

Lindsay Crossen is currently the Chairman at New Zealand Qualifications Authority, Director at Allied Funeral Home Ltd., Director at Southern Aggregates Ltd., and Director at InfraTrain New Zealand Ltd.
Previously, Mr. Crossen held positions as Acting Chief Executive Officer at Fulton Hogan Industries Pty Ltd., Independent Director at Lyttelton Port Co. Ltd., and Director at The NZ Institute of Highway Technology Ltd.

Laura Crossen served as the Chief Accounting Officer & Senior VP-Finance at 20230930-DK-Butterfly-1, Inc. from 2001 to 2023.
Prior to that, she was the Senior Vice President-Finance at dELiA*s, Inc. from 1998 to 2001.
She obtained an undergraduate degree from Providence College.

James Crossen is currently the Chief Financial & Accounting Officer at Apollo Strategic Growth Capital II, Acropolis Infrastructure Acquisition Corp., Apollo Strategic Growth Capital III, and Delphi Growth Capital Corp.
He previously worked as a Controller at Apollo Asset Management, Inc. from 2010 to 2014, as a Member-Funds Management & Tax Group at J.P.
Morgan Partners LLC from 2001 to 2005, as a Controller at Fortress Investment Group LLC from 2005 to 2007, as a Controller at Truvvo Partners LLC from 2007 to 2010, and as the Chief Financial & Accounting Officer at Spartan Energy Acquisition Corp.
from 2017 to 2020.
He also served as the Chief Financial & Accounting Officer at Apollo Strategic Growth Capital and Spartan Acquisition Corp.
II.
Mr. Crossen holds an undergraduate degree from the University of Connecticut, which he received in 1999.
Currently, he is the Secretary, Chief Financial & Accounting Officer at Spartan Acquisition Corp.
III.

Howard John Robert Crossen worked as a Senior Investment Director at Brooks Macdonald Asset Management Ltd.
from 2017 to 2022 and also worked as a Portfolio Manager at Premier Fund Managers Ltd.

James Michael Crossen currently works at Readypower Rail Services Ltd., as Director from 2022 and Readypower Group Ltd., as Chief Operating Officer.

Helen Thornhill currently works at King & Wood Mallesons LLP, as Head-Marketing.

Helen McLoughlin is currently working as a Director & Development Director at Waystone Ltd., as well as a Director at Waystone 32 Ltd.
and Waystone Developments Ltd.
She previously worked as a Director-Customer Services at MWUK Ltd.

Helen Chow is a member of CPA Australia Ltd.
and the Institute of Singapore Chartered Accountants.
She was previously the Secretary & Executive Director of Aussino Group Ltd.
from 2000 to 2010.
Currently, she is the Chief Financial Officer of Barramundi Group Ltd.
from 2016 to 2023.
Ms. Chow received an undergraduate degree from the National University of Singapore.

Helen G.
Drinan is currently the Director at Greater Boston Chamber of Commerce and a Trustee at Simmons University.
She previously worked as Vice Chairman at Blue Cross & Blue Shield of Massachusetts, Principal at BankBoston Corp., and Vice President at Arthur D.
Little, Inc. She also briefly served as Senior Vice President-Human Resources at Caritas Christi Health Care in 2003.
Drinan received her undergraduate degree from Mount Holyoke College and her graduate degree, including an MBA, from Simmons University.

Helen Wang worked as a Research Analyst at DBS Vickers Hong Kong Ltd.
(China), an Analyst at Societe Generale Asia Ltd.
and Indosuez W.I.
Carr Capital Asia Ltd., Head of Basic Materials at MF Global Hong Kong Ltd., Analyst at CLSA Research Ltd., and Senior Analyst at Atlantis Investment Management Ltd.
(Private Equity).
She holds an MBA from Wuhan University of Technology.

Helen Downey has been Chief Operating Officer of Berkshire Health Systems, Inc. since 2001.
Previously, she was Executive Director of the Berkshire Visiting Nurse Association and Vice President of Acute Care Services and Nursing for the Berkshire Medical Center.
Ms. Downey received an MBA from the University of Massachusetts.

Helen Tandler has been the President of Baycliff Co., Inc. since 1982.

Helen Springford is currently the Chief Executive Officer at Illingworth Research Group Ltd.
and the Vice President-Global Client Relations at Pharm-Olam International Ltd.
She previously worked as the VP-Global Business Development at Remedium Oy and as the Vice President-Business Development at Encorium Group, Inc.

Helen Dimoff currently works at NBBJ LP, as Chief Marketing Officer.

Helen Meyer is the founder of Meyer Sound Laboratories, Inc. which was founded in 1979.
She held the title of Executive Vice President.
Currently, she is a Director at San Francisco Opera Association and a Trustee-at-Large at Cal Performances.
In the past, she was a Trustee & Vice President at Berkeley Repertory Theatre Co. from 2012 to 2013.

Helen O'Bryne has been Secretary and General Counsel for ebookers Plc since September, 2001.
Prior to joining ebookers, she was Corporate Counsel for BBA Group Plc.
She joined the BBA Group in 1997.
Previously, she worked for Baker & McKenzie.
She attended the Leadership Programme at the Ashridge School of Management.
Earlier, she was a Lecturer at L'Universite de Paris.
Ms. O'Bryne received a Bachelor of Arts degree in French from Leeds University.

Helen R.
Friedli is currently a Director at Applied Power Investments II, Inc. and also holds a position at McDermott Will & Emery LLP.
Previously, she worked as a Secretary at Enerpac Tool Group Corp.

Helen Haynes is currently the Director of Human Resources and Quality Assurance at KeTech Group Ltd.
She previously worked as the Director of Human Resources at ClinPhone Ltd.
and as the Manager of Operations and Human Resources at PHF Services Ltd.

Helen Alison Pickford is currently a Director at Eagle Star Holdings Ltd., Zurich Financial Services (UKISA) Ltd., Zurich Holdings (UK) Ltd., Sterling ISA Managers Ltd., Zurich UK General Services Ltd., Zurich Employment Services Ltd., EFS Financial Services Ltd., Zurich Project Finance (UK) Ltd., and Chief Financial Officer at Reassure UK Life Assurance Co. Ltd.
In the past, she worked as a Finance Director at RSA Insurance Group Ltd.
and Ageas Insurance Ltd., Director at Zurich Intermediary Group Ltd., and Group Head-Investor Relations at RSA Insurance Group Ltd.

Helen Margaret Keays is currently an Independent Non-Executive Director at The Restaurant Group Plc, Nichols Plc, and SBT Trading Ltd.
She previously held positions as a Non-Executive Director at Britannia Building Society, Chrysalis Ltd., Naked Wines Plc, and Domino's Pizza Group Plc.
She also served as an Independent Non-Executive Director at Mattioli Woods Plc and Communisis Ltd.
Additionally, she was a Trustee at SBT Trading Ltd.
and a Non-Executive Director at Lasercare Clinics (Harrogate) Ltd., SKN Holdings Ltd., and TS Shelf Ltd.

Helen Reeves is Senior Vice President-Corporate Communications of MTS Allstream Inc., which she joined in 2006.
Ms. Reeves is a Director and Vice President of Harbourfront Corporation.
Previously, she was Vice President-Corporate Communications and Public Affairs of Stelco, Inc. and Vice President-Public Affairs, Communications and Marketing of Hydro Ottawa Holding, Inc. from 2001 to 2004.
Ms. Reeves was Vice President-Corporate and Public Affairs of Hydro One from 1999 to 2000 and Vice President-Communications of Noranda, Inc.

Helen Prosser currently works as a Director of Business Development and Marketing at LesterAldridge LLP.

Ms. Gaidatzis is co-head of GMO’s asset allocation advice and implementation in London.
Prior to joining GMO, she was responsible for providing investment advice to large private and public asset holders, typically pension funds, at JANA Investments, in Australia.
Ms. Gaidatzis holds a Bachelor of Economics degree with postgraduate first class honours from La Trobe University, Australia.

Ms. Helen Y.
Yang is a Managing Director of Business Services at American Capital Asset Management LLC.
Prior to joining American Capital Asset Management in January 2006, she was a Vice President at Lightyear Capital.
Previously, she was with Bankers Trust Capital Partners focusing on middle-market investments.
She began her career with Bear Stearns & Co. Inc., in the Health Care Investment Banking group.
Ms. Yang received a B.S.
from Massachusetts Institute of Technology, where she was elected to Phi Beta Kappa.
She received an M.B.A.
with honors from The Wharton School of the University of Pennsylvania.

Helen Rachelle Sinclair is the founder of Mobeus Equity Partners LLP, which was founded in 2004.
She held the title of Director during her time there.
Ms. Sinclair is also the founder of Mobeus Income & Growth 2 VCT Plc.
Her current job positions include Independent Non-Executive Chairman at Octopus Future Generations VCT Plc, Independent Non-Executive Director at Octopus Eclipse VCT 3 Plc, Independent Non-Executive Director at Shires Income Plc, Non-Executive Director at BlackRock Smaller Cos.
Trust Plc, Director at SMH Equity Partners Ltd., Director at North East Finance (Holdco) Ltd., Non-Executive Director at Sherborne Investors (Guernsey) C Ltd., and Director at North East Finance (Subco) Ltd.
Her former job positions include Chairman at Rockwood Strategic Plc, Chairman at British Smaller Cos.
VCT Plc, Non-Independent Non-Executive Director at The Income & Growth VCT Plc, Non-Executive Director at Downing Income VCT 4 Plc, Independent Non-Executive Director at WH Ireland Group Plc, Non-Executive Director at Mobeus Income & Growth 4 VCT Plc, Non-Executive Director at Thames Ventures VCT 1 PLC, Non-Executive Director at Future Thinking Ltd., Non-Executive Director at OFT 2 Ltd., and Executive Director at FTGS Holdco Ltd.Ms. Sinclair's education includes a graduate degree from the University of Cambridge and an MBA from INSEAD.

Helen Walsh worked as the Marketing Director at Candover Partners Ltd.
from 1997 to 2010.
She also worked as the Head of Marketing & Client Services at Hermes GPE LLP.
Ms. Walsh received an undergraduate degree from The University of Manchester in 1984.

Helen Raptis has been the Executive Director of Raptis Group Ltd.
since 2009.

Helen Wong worked as the Chief Financial Officer at Western Pacific Trust Co. from 2004 to 2011.

Helen C.
Adams is currently an Independent Director at Immix Biopharma, Inc. She previously held positions as Chairman at San Diego Athena, Independent Director at Genasys, Inc., Director at Turtle Beach Corp., Director at Young Womens Christian Association USA, Director at Corporate Directors Forum, Director at The Chairmen's RoundTable, Director at American Wind Energy Association, Director at Senior Community Centers, Director at Make-A-Wish Foundation of San Diego, Inc., Director at San Marcos Foundation, Independent Director at Prometheus Biosciences, Inc., Director at Athena Foundation, and Partner at Deloitte & Touche LLP.
She also served as Managing Partner-San Diego Chapter at Haskell & White LLP and Board Vice President at Children & Families of Iowa.
Ms. Adams obtained her undergraduate degree from San Diego State University.

Helen S.
Settles has a current job as a Director at Project Hospitality, Inc.